Literature DB >> 19699380

Psychiatric comorbidity and other psychological factors in patients with "chronic Lyme disease".

Afton L Hassett1, Diane C Radvanski, Steven Buyske, Shantal V Savage, Leonard H Sigal.   

Abstract

BACKGROUND: There is no evidence of current or previous Borrelia burgdorferi infection in most patients evaluated at university-based Lyme disease referral centers. Instead, psychological factors likely exacerbate the persistent diffuse symptoms or "Chronic Multisymptom Illness" (CMI) incorrectly ascribed to an ongoing chronic infection with B. burgdorferi. The objective of this study was to assess the medical and psychiatric status of such patients and compare these findings to those from patients without CMI.
METHODS: There were 240 consecutive patients who underwent medical evaluation and were screened for clinical disorders (eg, depression and anxiety) with diagnoses confirmed by structured clinical interviews at an academic Lyme disease referral center in New Jersey. Personality disorders, catastrophizing, and negative and positive affect also were evaluated, and all factors were compared between groups and with functional outcomes.
RESULTS: Of our sample, 60.4% had symptoms that could not be explained by current Lyme disease or another medical condition other than CMI. After adjusting for age and sex, clinical disorders were more common in CMI than in the comparison group (P <.001, odds ratio 3.54, 95% confidence interval, 1.97-6.55), but personality disorders were not significantly more common. CMI patients had higher negative affect, lower positive affect, and a greater tendency to catastrophize pain (P <.001) than did the comparison group. Except for personality disorders, all psychological factors were related to worse functioning. Our explanatory model based on these factors was confirmed.
CONCLUSIONS: Psychiatric comorbidity and other psychological factors are prominent in the presentation and outcome of some patients who inaccurately ascribe longstanding symptoms to "chronic Lyme disease."

Entities:  

Mesh:

Year:  2009        PMID: 19699380      PMCID: PMC2751626          DOI: 10.1016/j.amjmed.2009.02.022

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  44 in total

1.  Intralaboratory reliability of serologic and urine testing for Lyme disease.

Authors:  M S Klempner; C H Schmid; L Hu; A C Steere; G Johnson; B McCloud; R Noring; A Weinstein
Journal:  Am J Med       Date:  2001-02-15       Impact factor: 4.965

Review 2.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

3.  Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America.

Authors:  G P Wormser; R B Nadelman; R J Dattwyler; D T Dennis; E D Shapiro; A C Steere; T J Rush; D W Rahn; P K Coyle; D H Persing; D Fish; B J Luft
Journal:  Clin Infect Dis       Date:  2000-07       Impact factor: 9.079

4.  Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.

Authors:  Robert P Smith; Robert T Schoen; Daniel W Rahn; Vijay K Sikand; John Nowakowski; Dennis L Parenti; Mary S Holman; David H Persing; Allen C Steere
Journal:  Ann Intern Med       Date:  2002-03-19       Impact factor: 25.391

5.  Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease.

Authors:  N A Shadick; C B Phillips; O Sangha; E L Logigian; R F Kaplan; E A Wright; A H Fossel; K Fossel; V Berardi; R A Lew; M H Liang
Journal:  Ann Intern Med       Date:  1999-12-21       Impact factor: 25.391

6.  Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.

Authors:  M S Klempner; L T Hu; J Evans; C H Schmid; G M Johnson; R P Trevino; D Norton; L Levy; D Wall; J McCall; M Kosinski; A Weinstein
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

Review 7.  Improving inpatient antibiotic prescribing: insights from participation in a national collaborative.

Authors:  G D Schiff; M Wisniewski; J Bult; J P Parada; H Aggarwal; D N Schwartz
Journal:  Jt Comm J Qual Improv       Date:  2001-08

8.  Perspectives on "chronic Lyme disease".

Authors:  Phillip J Baker
Journal:  Am J Med       Date:  2008-07       Impact factor: 4.965

Review 9.  Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease.

Authors:  Mark S Klempner
Journal:  Vector Borne Zoonotic Dis       Date:  2002       Impact factor: 2.133

Review 10.  Contributions of societal and geographical environments to "chronic Lyme disease": the psychopathogenesis and aporology of a new "medically unexplained symptoms" syndrome.

Authors:  Leonard H Sigal; Afton L Hassett
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

View more
  21 in total

1.  A Comparison of Fibromyalgia Symptoms in Patients with Healthy versus Depressive, Low and Reactive Affect Balance Styles.

Authors:  Loren L Toussaint; Ann Vincent; Samantha J McAllister; Terry H Oh; Afton L Hassett
Journal:  Scand J Pain       Date:  2014-07-01

Review 2.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 3.  Lyme borreliosis.

Authors:  Allen C Steere; Franc Strle; Gary P Wormser; Linden T Hu; John A Branda; Joppe W R Hovius; Xin Li; Paul S Mead
Journal:  Nat Rev Dis Primers       Date:  2016-12-15       Impact factor: 52.329

Review 4.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

Review 5.  Unorthodox alternative therapies marketed to treat Lyme disease.

Authors:  Paul M Lantos; Eugene D Shapiro; Paul G Auwaerter; Phillip J Baker; John J Halperin; Edward McSweegan; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2015-04-06       Impact factor: 9.079

6.  Proof that chronic lyme disease exists.

Authors:  Daniel J Cameron
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-05-25

Review 7.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

Review 8.  Treatment trials for post-Lyme disease symptoms revisited.

Authors:  Mark S Klempner; Phillip J Baker; Eugene D Shapiro; Adriana Marques; Raymond J Dattwyler; John J Halperin; Gary P Wormser
Journal:  Am J Med       Date:  2013-06-10       Impact factor: 4.965

9.  Changes in Anxiety and Depression Are Mediated by Changes in Pain Severity in Patients Undergoing Lower-Extremity Total Joint Arthroplasty.

Authors:  Afton L Hassett; Elizabeth Marshall; Angela M Bailey; Stephanie Moser; Daniel J Clauw; W Michael Hooten; Andrew Urquhart; Chad M Brummett
Journal:  Reg Anesth Pain Med       Date:  2018-01       Impact factor: 6.288

10.  The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms.

Authors:  Robert C Bransfield
Journal:  Open Neurol J       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.